Hauwa U., 7

Hauwa Umar is a 7-year-old girl with sickle cell disease who lives with her widowed mother and siblings in unstable living conditions. Despite their struggles with poverty and displacement, Hauwa remains a bright child who enjoys drawing and playing with friends. She presented to Adari Medical Clinic on 5th June 2026 with a 3-day history of high fever, chills, severe bone pain, headache, and increasing weakness. Her mother also reported reduced oral intake and lethargy. On examination, she was febrile, pale, and in significant distress due to generalized body pain. Investigations confirmed Plasmodium falciparum malaria with anemia, triggering a sickle cell pain crisis. She was admitted from 5th to 9th June 2026 and managed with intravenous antimalarials, analgesia, fluids, and blood transfusion. She improved with treatment and was closely monitored throughout admission.

Hauwa, a seven-year-old girl with sickle cell disease, was brought to Adari Medical Clinic by her mother with a history of fever and severe bone pain. Following clinical evaluation and laboratory confirmation of malaria complicated by sickle cell crisis, she was admitted for intravenous antimalarials, pain management, blood transfusion, intravenous fluids, and bed rest. Her mother was educated on the importance of malaria prevention, hydration, and early recognition of sickle cell complications. At discharge four days later, Hauwa showed marked improvement, with resolution of fever and significant reduction in pain. She was continuing her recovery and was advised to continue bed rest and follow-up care. We thank Helpster Charity Foundation for providing the support that made Hauwa's treatment and recovery possible.

Hauwa Umar, a seven-year-old girl with sickle cell disease, presented with fever, severe bone pain, headache, and weakness. Laboratory tests confirmed malaria (parasitemia 2.4%) and severe anemia (hemoglobin 7.8 g/dL). She was diagnosed with malaria complicated by sickle cell crisis. Because of her underlying sickle cell disease, the risk of complications such as acute chest syndrome, stroke, and severe anemia was high. She needed intravenous antimalarials, pain management, intravenous fluids, blood transfusion, and bed rest. She was admitted for 4 days and received intravenous artesunate, intravenous fluids, intravenous paracetamol for pain, blood transfusion (one unit), and nutritional support. Her pain improved with pain management, and her hemoglobin increased to 9.6 g/dL by discharge. At discharge, she was afebrile, alert, and stable.